Skip to search formSkip to main contentSkip to account menu

acetylacetoin reductase (NADH)

Known as: AACR II 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
In addition to mutations or aberrant expression in the protein-coding genes, mutations and misregulation of noncoding RNAs, in… 
Review
2017
Review
2017
  • L. Emens
  • Clinical Cancer Research
  • 2017
  • Corpus ID: 20996173
Immunotherapy is revolutionizing the management of multiple solid tumors, and early data have revealed the clinical activity of… 
Highly Cited
2016
Highly Cited
2016
Purpose: Approximately one-third of patients with non–small cell lung cancer (NSCLC) harboring tumors with EGFR-tyrosine kinase… 
Highly Cited
2016
Highly Cited
2016
Hypoxia is a common feature of solid tumors and is associated with aggressiveness and poor patient outcomes. Exosomes, initially… 
Review
2016
Review
2016
DNA methylation is known to be abnormal in all forms of cancer, but it is not really understood how this occurs and what is its… 
Highly Cited
2016
Highly Cited
2016
Small-molecule inhibitors of the CDK4/6 cell-cycle kinases have shown clinical efficacy in estrogen receptor (ER)-positive… 
Highly Cited
2016
Highly Cited
2016
Purpose: To identify baseline peripheral blood biomarkers associated with clinical outcome following ipilimumab treatment in… 
Highly Cited
2016
Highly Cited
2016
Purpose: Recommendations for adjuvant treatment for women with early-stage endometrial carcinoma are based on clinicopathologic… 
Highly Cited
2016
Highly Cited
2016
Purpose: An anti-HER2 antibody–drug conjugate with a novel topoisomerase I inhibitor, DS-8201a, was generated as a new antitumor… 
Review
2015
Review
2015
UNLABELLED The ability of cancer cells to suppress apoptosis is critical for carcinogenesis. The BCL2 family proteins comprise…